CUP Belumosudil

Hematological neoplasms
Other indications (e.g. myeloproliferative diseases)
other systemic therapies
For the treatment chronic graft-versus-host disease (cGvHD) in adult patients after failure of at least two previous lines of systemic therapy
For the treatment chronic graft-versus-host disease (cGvHD) in adult patients after failure of at least two previous lines of systemic therapy